The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...

SNP genotyping is an exciting field. The completion of the human genome sequencing project has enabled SNP research to move forward. SNP genotyping allows for further characterization of the human ...

In recent years, the rise of next-generation sequencing (NGS) has unlocked new dimensions in variant detection. However; single nucleotide polymorphism (SNP) genotyping often remains dependent on ...

Lettuce (L. sativa L., 2n = 2x = 18) is an agricuturally important leafy vegetable cultivated predominantly in temperate climates and produced in large quantities in Korea. The complete decoding of ...

Take any two individuals, sequence and compare their genomic DNA, and you'll find that the vast majority (about 99.9%) of the sequences are identical. In the remaining 0.1% lie differences in disease ...

CMD-related SNPs. CMD, coronary microvascular dysfunction; SNP, single nucleotide polymorphism. The findings suggest that a genetics-driven approach could revolutionize CMD diagnosis and treatment, ...

Exclusive high dose rate brachytherapy (HDR-BT) for early stage non-small cell lung carcinoma: Results of a retrospective study in 226 patients ...

In a recent article published in Nature Medicine, researchers investigated the potential implications of single-nucleotide variations in gut-residing bacterial species (microbiome) on human health.

Mice and rats are a fundamental component of drug discovery research. Standard outbred stocks and inbred strains of rodents are used extensively for drug safety and pharmacokinetic testing. Our ...